Taylor J R, Elsworth J D, Roth R H, Collier T J, Sladek J R, Redmond D E
Neurobehavior Laboratory, Yale University School of Medicine, New Haven, CT 06510.
Prog Brain Res. 1990;82:543-59. doi: 10.1016/s0079-6123(08)62645-x.
Improvements in MPTP-induced deficits were only found in subjects that received fetal substantia nigra transplants into the caudate nucleus. The MPTP-induced deficits were assessed using an object retrieval task that examined cognitive and subtle motor performance and by behavioral observation to determine the overall status of the subjects. Subjects that were also moderately or severely impaired by MPTP administration but that received inappropriate donor cells or implant sites (cerebellum to CN or SN to cortex) did not show any evidence of behavioral recovery. These subjects could not respond on the task in the months after grafting and were sacrificed, showing no improvements in parkinsonian signs or healthy behavior signs, up to 5-6 months after surgery. Grafting of SN cells into the striatum of non-MPTP lesioned subjects failed to modify normal behavior or induce abnormal behavior determined by our 2 behavioral assessment methods. In those monkeys that received the appropriate transplants, TH immunohistochemistry revealed that cells of the fetal substantia nigra grafted into the caudate nucleus survived and extended neurites into the host striatum. Indeed, grafted dopamine neurons were often associated with appreciable innervation of the caudate nucleus and appeared to be well incorporated into the host brain. In contrast, examination of the striatum of subjects in the inappropriate-graft group (e.g., cerebellar cells grafted into the caudate) showed no evidence of TH staining within the graft or host caudate nucleus. This indicated that there was no evidence of dopamine neurons present in the grafted tissue and that the mere presence of a fetal graft did not appear to induce sprouting in these MPTP-treated subjects. Although behavioral recovery occurred in only those monkeys that received appropriate transplants (fetal SN to host CN) and not in those that received inappropriate grafts (fetal cerebellum to CN or fetal SN to cortex), the CSF HVA levels did not distinguish those monkeys with improved parkinsonism from those that remained severely parkinsonian. The finding that in some SN-CN grafted subjects reported here, there was evidence of increased dopamine and lowered HVA/dopamine ratio in the vicinity of the SN grafts (cf. Elsworth et al., 1990b) is consistent with the hypothesis that graft-derived or graft-induced dopamine production is responsible for behavioral recovery. In addition, the finding that CSF HVA levels in non-MPTP lesioned subjects were unchanged by fetal SN grafts further indicates that CSF HVA levels may not be sufficiently sensitive to changes in central dopamine production to reflect release of dopamine from relatively small grafts that may, in lesioned subjects, modify behavior.(ABSTRACT TRUNCATED AT 400 WORDS)
仅在将胎儿黑质移植到尾状核的受试者中发现了MPTP诱导的缺陷有所改善。使用物体检索任务评估MPTP诱导的缺陷,该任务检查认知和细微运动表现,并通过行为观察来确定受试者的整体状态。那些也因MPTP给药而中度或重度受损,但接受了不适当供体细胞或植入部位(小脑移植到尾状核或黑质移植到皮层)的受试者没有表现出行为恢复的任何迹象。这些受试者在移植后的几个月内无法对任务做出反应并被处死,在手术后长达5 - 6个月内,帕金森症状或健康行为体征均未改善。将黑质细胞移植到未受MPTP损伤的受试者纹状体中,未能改变正常行为或通过我们的两种行为评估方法诱导异常行为。在那些接受了适当移植的猴子中,TH免疫组织化学显示移植到尾状核的胎儿黑质细胞存活并向宿主纹状体延伸神经突。实际上,移植的多巴胺神经元通常与尾状核的明显神经支配相关,并且似乎很好地融入了宿主大脑。相比之下,对不适当移植组受试者(例如,小脑细胞移植到尾状核)的纹状体检查显示,移植组织或宿主尾状核内没有TH染色的证据。这表明移植组织中没有多巴胺神经元存在的证据,并且仅仅胎儿移植的存在似乎并未在这些MPTP处理的受试者中诱导发芽。尽管行为恢复仅发生在那些接受了适当移植(胎儿黑质移植到宿主尾状核)的猴子中,而不是那些接受了不适当移植(胎儿小脑移植到尾状核或胎儿黑质移植到皮层)的猴子中,但脑脊液高香草酸(HVA)水平并不能区分帕金森症状改善的猴子和仍严重帕金森的猴子。此处报道的一些黑质 - 尾状核移植受试者中,在黑质移植附近有多巴胺增加和HVA/多巴胺比率降低的证据(参见Elsworth等人,1990b),这一发现与移植来源或移植诱导的多巴胺产生导致行为恢复的假设一致。此外,未受MPTP损伤的受试者脑脊液HVA水平未因胎儿黑质移植而改变这一发现进一步表明,脑脊液HVA水平可能对中枢多巴胺产生的变化不够敏感,无法反映来自相对较小移植的多巴胺释放,而这些移植在受损受试者中可能会改变行为。(摘要截断于400字)